[en] FunctionaL coLopathy: stiLL reLevant? Let's move to irritabLe boweL syndrome. summary : Irritable bowel syndrome is a functional disorder that is frequently encountered in general practice as well as in specialized consultations. Diagnostic criteria have been well established but there is currently no specific diagnostic test. The various gastroenterology societies have recently published recommendations for diagnostic and therapeutic management adapted to the pathophysiology and the availability of treatments in different countries. This article summarizes the main lines of these recommendations and in particular those of the Belgian consensus.
Disciplines :
Gastroentérologie & hépatologie
Auteur, co-auteur :
Latour, Pascale ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Louis, Edouard ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gastroentérologie, hépatologie, onco. digestive
Langue du document :
Français
Titre :
La colopathie fonctionnelle : toujours d’actualité ? Place au syndrome de l’intestin irritable
Titre traduit :
[en] FunctionaL coLopathy: still relevant? Let’s move to irritabLe boweL syndrome.
Date de publication/diffusion :
juin 2023
Titre du périodique :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Maison d'édition :
Université de Liège. Revue Médicale de Liège, Liège, Belgique
Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol 2021;116:17-44.
Sabate JM POST’U 2022. Available from: https://www.fmcgastro.org/wp-content/uploads/2021/09/147_022_SABATE.pdf.
Kindt S, Louis H, De Schepper H, et al. Belgian consensus on irritable bowel syndrome. Acta Gastroenterol Belg 2022;85:360-82.
Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 2016;18:S0016-5085(16)00222-5.
Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997;32:920-4.
Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology 2021;160:99-114.e3.
Van den Houte K, Carbone F, Pannemans J, et al. Prevalence and impact of self-reported irritable bowel symptoms in the general population. United European Gastroenterol J 2019;7:307-15.
Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000;46:78-82.
McKenzie YA, Bowyer RK, Leach H, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). JHumNutrDiet2016;29:549-75.
Eswaran SL, Chey WD, Han-Markey T, et al. A randomized controlled trial comparing the low FODMAP Diet vs. modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol 2016;111:1824-32.
Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014;146:67-75.e5.
Moayyedi P, Mearin F, Azpiroz F, et al. Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice. United European Gastroenterol J 2017;5:773-88.
Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008;337:a2313. Erratum in: BMJ 2009;338:b1881.
Drossman DA, Tack J, Ford AC, Szigethy E, et al. Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a rome foundation working team report. Gastroenterology 2018;154:1140-71.e1.
Ford AC, Harris LA, Lacy BE, et al. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2018;48:1044-60.
Shah ED, Kim HM, Schoenfeld P. Efficacy and tolerability of Guanylate Cyclase-C agonists for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysis. Am J Gastroenterol 2018;113:329-38.
Layer P, Stanghellini V. Review article: Linaclotide for the management of irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2014;39:371-84.
Ford AC, Lacy BE, Harris LA, et al. Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol 2019;114:21-39.
Black CJ, Thakur ER, Houghton LA, et al. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 2020;69:1441-51.
Zhou C, Zhao E, Li Y, et al. Exercise therapy of patients with irritable bowel syndrome: A systematic review of randomized controlled trials. Neurogastroenterol Motil 2019;31:e13461.
